Mazdutide 10 mg

Price range: $200.39 through $239.33

  • Product name: Mazdutide
  • Labeled quantity: 10 mg
  • Physical form: Lyophilized powder
  • Packaging: One boxed 3 mL vial
  • Compound type: Modified peptide
  • Receptor targets studied: GLP-1 and glucagon receptors
  • Visit COA Results 
United States dollar ($) - USD
  • United States dollar ($) - USD
Select delivery location

Mazdutide 10 mg Research Peptide

Product Overview

Explore Mazdutide 10 mg from Pure Lab Peptides Supply, supplied as lyophilized powder in one boxed 3 mL vial for laboratory research. Mazdutide is a modified peptide studied for its activity at glucagon-like peptide-1 (GLP-1) and glucagon receptors.

Because it targets two distinct receptor types, Mazdutide is described as a dual agonist. Researchers investigate this activity in studies of receptor signaling and metabolic pathways. For product information and available batch documentation, visit Pure Lab Peptides Supply and the COA and document page.

Product Information

  • Product name: Mazdutide
  • Labeled quantity: 10 mg
  • Physical form: Lyophilized powder
  • Packaging: One boxed 3 mL vial
  • Compound type: Modified peptide
  • Receptor targets studied: GLP-1 and glucagon receptors
  • Intended use: Laboratory research only; not for human or veterinary use

Choose the Correct Presentation and Named Analog

The Mazdutide 10 mg presentation contains a different labeled quantity from the Mazdutide 5 mg presentation. Both listings refer to the same named compound, but the milligram value identifies the stated material mass, not a liquid concentration or a measure of receptor potency.

Survodutide is another compound studied at GLP-1 and glucagon receptors. However, it is a distinct analog rather than an alternative name for Mazdutide. Although both compounds share receptor targets, this similarity does not establish equal activity or make the materials interchangeable.

The term dual agonist describes activity at two receptor types. In this case, Mazdutide is one modified peptide, not a mixture of separate GLP-1 and glucagon ingredients.

When comparing research materials, therefore, check the compound identity, specified peptide form, and available product records rather than relying on receptor classifications alone.

Scientific Background: Connecting Mazdutide to Published Research

Identifying Mazdutide in the Literature

The publication by Ji and colleagues identifies Mazdutide using the development names IBI362 and LY3305677. These identifiers help researchers locate relevant studies and distinguish this analog from other compounds that act at GLP-1 and glucagon receptors.

The publication reports a clinical trial involving a defined investigational formulation. It provides scientific context for the compound’s identity and development; however, it does not establish the formulation, clinical suitability, or expected effects of this specific research powder.

Furthermore, research findings must be interpreted in the context of the material and methods actually studied. A clinical formulation described in a publication should not automatically be treated as equivalent to a separately supplied laboratory material.

For accurate comparisons, match the specified peptide form and modifications to the product documentation. A shared name or receptor category cannot replace that identity check.

COA and Batch Documentation

Before evaluating this research material, review the available records through the COA and document page. Match the product name and lot identifier, then check which analytical tests the corresponding report documents.

Identity, chromatographic purity, and measured content answer different questions. For example, a chromatographic purity result describes the sample profile under the analytical method used, but it does not independently establish the total peptide quantity in the vial or its biological activity.

Likewise, published studies on Mazdutide cannot verify the characteristics of an individual commercial batch. Consequently, researchers should evaluate batch-specific documentation separately from the scientific literature.

For additional product information, visit Pure Lab Peptides Supply.

Packaging and Research Considerations

Mazdutide 10 mg is supplied as lyophilized powder in one boxed 3 mL vial. The 3 mL figure describes the vial’s capacity; it does not specify a liquid fill volume, solution concentration, or preparation procedure.

Researchers should follow the applicable product records and laboratory protocols for handling, storage, and analysis. In addition, any comparison between materials should account for compound identity, supplied form, and the methods used to evaluate each sample.

This product is intended for laboratory research only and is not intended for human or veterinary use.

Frequently Asked Questions

What is Mazdutide?

Mazdutide is a modified peptide studied for activity at GLP-1 and glucagon receptors. Researchers can use its development identifiers, IBI362 and LY3305677, to locate relevant scientific literature.

What does Mazdutide 10 mg mean?

Mazdutide identifies the compound, while 10 mg indicates the labeled quantity of material. Neither specification defines a liquid concentration or receptor potency.

How does Mazdutide 10 mg differ from Mazdutide 5 mg?

The presentations differ in their labeled material quantities. Both use the same named compound, but researchers should confirm the product records for the specific presentation being evaluated.

Is Mazdutide the same as Survodutide?

No. Although both compounds have been studied at GLP-1 and glucagon receptors, they are distinct analogs. Shared receptor targets do not establish equivalent activity or interchangeability.

Is Mazdutide supplied as a prepared solution?

No. This listing describes lyophilized powder in a boxed 3 mL vial. Vial capacity does not specify a liquid fill volume or preparation procedure.

Where can I review available batch reports?

Visit the COA and document page to review available product files and analytical reports. Always match the report’s product and lot identifiers to the material under evaluation.

Research Documentation and Product Review

Mazdutide 10 mg provides a defined compound identity for laboratory research involving GLP-1 and glucagon receptor signaling. However, researchers should distinguish published findings about the named analog from batch-specific analytical results and product characteristics.

To review product information and available documentation, visit Pure Lab Peptides Supply and the COA and document page.

Select Quantity

1 Vial, 2 Vials, 3 Vials, 5 Vial s

0
0
Your Cart
Empty CartYour cart is emptyReturn to Shop
Secure Checkout
Fast Shipping
Easy Returns